medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2011, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2011; 9 (4)

Pityriasis alba in the pediatric population. A clinical and therapeutic approach

Aguilar UPV, Boungermini GA, Valencia HAM, Toledo BM, Ramírez CE, Mena CCA

Language: Spanish
References: 35
Page: 286-291
PDF size: 149. Kb.


ABSTRACT

Pityriasis alba (PA) is a common condition in childhood. It is the third cause of our pediatric consultation at the Hospital General de México, and the fourth most common cause of external consultation at the National Institute of Pediatrics. Its etiology is unknown, and it has no effective treatment. It is among the minor criteria to diagnosis atopic dermatitis (AD). Therefore, many authors treat it as such, but always with a poor response to the multiple regimens, including emollients, sunscreens, topical steroids, and calcineurin inhibitors.


REFERENCES

  1. Richie L, Janniger MC. “Pityriasis Alba”. Cutis 2005; 76: 21-24.

  2. O’Farrel NM. “Pityriasis alba”. Arch Dermatol 1956; 73: 373-377.

  3. Blessmann M, Sponchiado L, Ferreira T. “Pitiríase Alba. Aspectos epidemiológicos clínicos e terapêuticos”. An Brás Dermatol Rio de Janeiro 2000; 75(3): 359-367.

  4. Weber B, Sponchiado de Ávila L, Albaneze R, Magalhães de Oliveira O, Sudhaus B, Ferreira T. “Pityriasis Alba: A study of pathogenic factors”. JEADV 2002; 16: 463-468.

  5. Hanifin J, Rajka G. “Diagnostic features of atopic dermatitis”. Acta Venerol (Stockh) 1980; 92(suppl): 44-47.

  6. Magaña M, Vásquez R, González N. “Dermatología pediátrica en el Hospital General Frecuencia de las enfermedades de la piel del niño en 10000 consultas 1990-1994”. Rev Med Hosp Gen Mex 1995; 58(3): 124- 130.

  7. Fung WK, Lo KK. “Prevalence of skin disease school children and adolescents in a Student Health Service Center in Hong Kong”. Pediatr Dermatol 2000; 17(6): 440-446.

  8. Martínez R, Pastrana F, Ramírez C, Naranjo M, Ortiz P. “Morbilidad por afecciones dermatológicas. Estudio estadístico territorial”. Ver Cubana Pediatr 1999; 71(2): 53-59.

  9. Mayeshiro E, Anadela L, Velásquez F, Bravo F, Cáceres H. “Características clínico-patológicas de la Pitiriasis Alba. Estudio prospectivo con 31 casos”. Dermatol Pediatr Lat 2005; 3(1): 27-37.

  10. Nanda A, Al-Hasawi F, Alsaleh QA. “A prospective Surrey of pediatric dermatology clinic patients in Kuwait: an analysis of 10000 cases”. Pediatr Dermatol 1999 Jan-Feb; 16(1): 6-11.

  11. Arenas R. “Pitiriasis alba”. En Dermatología, atlas, diagnóstico y tratamiento, México, McGraw-Hill Interamericana, 1997: 75-76.

  12. Inanir I, Sahin MT, Gunduz K, et al. “Prevalence of skin condition in primary school children in Turkey: differences based on socioeconomic factors”. Pediatr Dermatol. 2002; 19: 307-311.

  13. Uriarte Félix J, Sáez de Ocariz M, Durán Mckinster C, Orozco Covarrubias L, Julián González R, Ruíz Maldonado R. “Variación estacional de las dermatosis más frecuentes en una consulta externa de Dermatología Pediátrica en México”. Dermatol Pediatr Lat 2005; 3(1): 21-25.

  14. Bassaly M, Miale A. “Studies on pityriasis alba a common facial skin lesion in Egyptian children”. Arch Dermatol 1963; 88: 272-3.

  15. Wells BT, White HJ, Kierland RR. “Pityriasis alba: a ten year survey and review of the literature”. Arch Dermatol 1960; 82: 183-189.

  16. Mevorah B, Frank E, Wietlisbach V, et al. “Minor clinical features of atopic dermatitis”. Dermatológica 1988; 177: 360-364.

  17. Cáceres H, Rueda M. “Dermatitis atópica”. Dermatología Peruana 1999; 9(2): 24-31.

  18. Unna PG, Abadía C. “Pitiriase Alba: Estudio clínico e microbiológico”. Tesis de mestría, Universidad Federal de Río de Janeiro, Brasil, 1992: 168.

  19. Galadari E, Helmy M. “Trace elements in serum of pityriasis alba patients”. Int J Dermatol 1992; 31(7): 525-526.

  20. Du Toit MJ, Jordaan HF. “Pigmenting pityriasis alba”. Pediatr Dermatol 1993; 10(1): 1-5.

  21. Fitzpatrick T, Eisen A, Wolff K, Freedberg I, Austen F. Dermatología en Medicina General. 4ª Ed. Buenos Aires, Editorial Médica Panamericana, 1997: 101-102.

  22. Zaynoun ST, Aftimos BG, Tenekjian KK, Bahuth N, Kurban AK. “Extensive pityriasis alba: A histological, histochemical and ultrastructural study”. Br J Dermatol 1983; 108(1): 83-90.

  23. Díaz LH. “Pitiriasis Alba: aspectos epidemiológicos, clínicos y terapéuticos”. Revista de la Universidad Autónoma de Bucaramanga 2003; 6: 168- 172.

  24. Falabella R. “Nongenetic disorders of hypopigmentation in Schachner”. En Hansen R. Pediatric Dermatology, 3a ed. Londres, Mosby Ltd. 2003: 504-513.

  25. Vargas-Ocampo F. “Pityriasis alba: A Histologic study”. Int J Dermatol 1993; 32(12): 870-387.

  26. Pasquel A, Palacios S, Cañarte C. “Estudio comparativo de la eficacia entre la pasta de zinc 10% vs pasta de zinc 10% más hidrocortisona 1% en pitiriasis alba en niños”. Dermatol Pediatr Lat 2006; 4(1): 28-35.

  27. Ruíz Avila P, Tercedor J. “Técnicas de diagnóstico Utilidad de la luz de Wood en Dermatología”. Piel 1994; 9: 408-412.

  28. Paller A, Eichenfield LF, Leung DY, Stewart D, Appell M. “A 12 week study of Tacrolimus treatment of atopic dermatitis in pediatric patients”. J Am Acad Dermatol 2001, 44: S47-S57.

  29. Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC. “Efficacy and tolerability of topical Pimecrolimus and Tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomized controlled trials”. BMJ 2005; 330: 516-522.

  30. Billich A, Aschauer H, Aszodi A, Stuetz A. “Percutaneous absorption of drugs used in atopic eczema: Pimecrolimus permeates less through skin than corticosteroids and Tacrolimus”. Int J Pharm 2004; 269: 29- 35.

  31. Papp KA, Breuer K, Meurer M, Ortone JP, Potter PC, de Prost Y, et al. “Long-term treatment of atopic dermatitis with Pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination”. J Am Acad Dermatol 2005; 52: 247-253.

  32. Rustin MHA. “The safety of tacrolimus ointment for the treatment of atopic dermatitis: A review”. B J Dermatol 2007; 157: 861-873.

  33. Gonzalez Ochoa A, Vargas Ocampo F. “Treatment of pityriasis alba with combination of coaltar, diiodohidoxyquinolin and hydrocortisone”. Med Cutan Ibero Lat Am 1980; 8: 69-72

  34. Fujita H, Wayne H, Mc Cormick, Calogera L BA, Parneix-Spake, A. “An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba”. Inter Journal of Dermatol 2007; 46 (7): 700-705.

  35. Rigopoulos D, Gregoriou S, Charissi C, Kontochristopoulos G, Kalogeromitros D, Georgala S. “Tacrolimus ointment 0.1% in pityriasis Alba: an open-label, randomized, placebo-controlled study”. Br J Dermatol 2006; 155: 152-155.




2020     |     www.medigraphic.com